Prestige Wealth Management Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.2K | Sell |
486
-21
| -4% | -$2.26K | 0.01% | 250 |
|
|
2025
Q1 | $51.1K | Sell |
507
-200
| -28% | -$20.2K | 0.01% | 246 |
|
|
2024
Q4 | $63.2K | Sell |
707
-1
| -0.1% | -$89 | 0.01% | 236 |
|
|
2024
Q3 | $59.3K | Hold |
708
| – | – | 0.01% | 235 |
|
|
2024
Q2 | $54.5K | Sell |
708
-5
| -0.7% | -$385 | 0.01% | 216 |
|
|
2024
Q1 | $48.8K | Hold |
713
| – | – | 0.01% | 255 |
|
|
2023
Q4 | $41.2K | Sell |
713
-99
| -12% | -$5.72K | 0.01% | 259 |
|
|
2023
Q3 | $42.9K | Hold |
812
| – | – | 0.01% | 253 |
|
|
2023
Q2 | $43.9K | Sell |
812
-15
| -2% | -$811 | 0.01% | 271 |
|
|
2023
Q1 | $41.4K | Buy |
827
+7
| +0.9% | +$350 | 0.01% | 258 |
|
|
2022
Q4 | $37.9K | Buy |
820
+4
| +0.5% | +$185 | 0.01% | 281 |
|
|
2022
Q3 | $32K | Buy |
816
+61
| +8% | +$2.39K | 0.01% | 264 |
|
|
2022
Q2 | $28K | Sell |
755
-48
| -6% | -$1.78K | 0.01% | 285 |
|
|
2022
Q1 | $35K | Buy |
803
+81
| +11% | +$3.53K | 0.01% | 272 |
|
|
2021
Q4 | $31K | Buy |
722
+5
| +0.7% | +$215 | 0.01% | 306 |
|
|
2021
Q3 | $31K | Hold |
717
| – | – | 0.01% | 305 |
|
|
2021
Q2 | $31K | Sell |
717
-36
| -5% | -$1.56K | 0.01% | 292 |
|
|
2021
Q1 | $30K | Buy |
753
+222
| +42% | +$8.85K | 0.01% | 301 |
|
|
2020
Q4 | $19K | Buy |
531
+34
| +7% | +$1.22K | 0.01% | 361 |
|
|
2020
Q3 | $19K | Hold |
497
| – | – | 0.01% | 356 |
|
|
2020
Q2 | $18K | Hold |
497
| – | – | 0.01% | 346 |
|
|
2020
Q1 | $16K | Buy |
497
+191
| +62% | +$6.15K | 0.01% | 315 |
|
|
2019
Q4 | $14K | Sell |
306
-7
| -2% | -$320 | 0.01% | 321 |
|
|
2019
Q3 | $13K | Buy |
313
+13
| +4% | +$540 | 0.01% | 315 |
|
|
2019
Q2 | $13K | Hold |
300
| – | – | 0.01% | 304 |
|
|
2019
Q1 | $12K | Sell |
300
-228
| -43% | -$9.12K | 0.01% | 321 |
|
|
2018
Q4 | $19K | Buy |
+528
| New | +$19K | 0.01% | 314 |
|